The Real Cost Campaign
Outcomes Evaluation Study: Cohort 3 (Outcomes Study)
No
material or nonsubstantive change to a currently approved
collection
No
Regular
10/18/2024
Requested
Previously Approved
06/30/2026
06/30/2026
1,131,408
856,316
154,921
115,399
0
0
This proposed information collection
supports the U.S. Food and Drug Administration’s (FDA) efforts to
assess campaign effectiveness. The Center for Tobacco Products
(CTP) is proposing to conduct a quantitative study of the effects
of FDA’s The Real Cost campaign on youth in the U.S. The purpose of
FDA’s The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 is
to evaluate whether changes in key outcomes can be attributed to
campaign exposure. We intend to measure self-reported campaign
exposure to media advertising, which among many things, will enable
FDA to assess its relationship with market-level delivery. The
study will be conducted using web-based surveys that are
self-administered on personal computers or web enabled mobile
devices.
PL:
Pub.L. 111 - 31 1 Name of Law: Family Smoking Prevention and
Tobacco Control Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.